State Street’s CASI Pharmaceuticals CASI Stock Holding History

State Street’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,555	Closed	-$81.8K	–	4682
2023 Q1	$81.8K	Hold	35,555	–	–	﹤0.01%	4382
2022 Q4	$62.2K	Hold	35,555	–	–	﹤0.01%	4505
2022 Q3	$92K	Hold	35,555	–	–	﹤0.01%	4488
2022 Q2	$102K	Hold	35,555	–	–	﹤0.01%	4526
2022 Q1	$288K	Buy	35,555 +2,341	+7%	+$18.4K	﹤0.01%	4255
2021 Q4	$266K	Hold	33,214	–	–	﹤0.01%	4225
2021 Q3	$395K	Buy	33,214 +13,730	+70%	+$186K	﹤0.01%	4069
2021 Q2	$302K	Sell	19,484 -84,490	-81%	-$1.42M	﹤0.01%	4047
2021 Q1	$2.5M	Sell	103,974 -3,428	-3%	-$96.3K	﹤0.01%	3347
2020 Q4	$3.17M	Buy	107,402 +5,641	+6%	+$123K	﹤0.01%	3171
2020 Q3	$1.56M	Buy	101,761 +6,238	+7%	+$117K	﹤0.01%	3293
2020 Q2	$2.39M	Buy	95,523 +4,727	+5%	+$103K	﹤0.01%	3110
2020 Q1	$1.85M	Sell	90,796 -4,337	-5%	-$103K	﹤0.01%	3095
2019 Q4	$2.94M	Buy	95,133 +7,619	+9%	+$247K	﹤0.01%	3099
2019 Q3	$2.92M	Buy	87,514 +436	+0.5%	+$14K	﹤0.01%	3069
2019 Q2	$2.79M	Buy	87,078 +7,560	+10%	+$241K	﹤0.01%	3103
2019 Q1	$2.28M	Buy	79,518 +2,887	+4%	+$101K	﹤0.01%	3107
2018 Q4	$3.08M	Sell	76,631 -1,686	-2%	-$63.9K	﹤0.01%	2936
2018 Q3	$3.66M	Buy	78,317 +19,001	+32%	+$1.33M	﹤0.01%	3013
2018 Q2	$4.88M	Buy	59,316 +56,953	+2,410%	+$3.84M	﹤0.01%	2864
2018 Q1	$99K	Buy	+2,363	New	+$88.2K	﹤0.01%	3615

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street's CASI Position: Q2 2023 in Review

State Street sold out of CASI Pharmaceuticals (CASI) in Q2 2023, closing a stake of 35,555 shares — an estimated $81.8K sold.

State Street first reported a position in CASI in Q1 2018 and held it in 21 quarters. The position peaked at $4.88M in Q2 2018. 19 funds tracked by Wall St. Rank hold CASI as of Q2 2023.

State Street reported no remaining CASI Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
State Street sold 35,555 CASI Pharmaceuticals shares in Q2 2023, an estimated $81.8K.
State Street first reported a position in CASI Pharmaceuticals in Q1 2018 and held it in 21 quarters.
State Street's CASI Pharmaceuticals position peaked at $4.88M in Q2 2018.
19 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.